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Abstract
Cytotrophoblasts are specialized epithelial cells of the human placenta that differentiate to acquire tumor-like properties that allow them
to invade the uterus. Concurrently, they develop endothelial-like characteristics. This transformation allows cytotrophoblasts to replace the
maternal cells that line uterine vessels, thereby diverting maternal blood to the placenta. Previously, we showed that invading cytotropho-
blasts secrete VEGF-C and PlGF, factors that regulate their acquisition of an endothelial-like phenotype. Here, we examined the cells’
expression of angiopoietin ligands and their Tie receptors. The data show that cytotrophoblasts predominantly expressed Ang2. We also
studied the paracrine functions of Ang2 and the VEGFs by culturing uterine microvascular endothelial cells in cytotrophoblast-conditioned
medium, which supported their growth. Removal of VEGF-C, PlGF, and/or Ang2 from the medium caused a marked reduction in cell
number due to massive apoptosis. We also assayed the angiogenic potential of cytotrophoblast-derived factors in the chick chorioallantoic
membrane assay. The results showed that they stimulated angiogenesis to a level comparable to that of basic FGF. These data suggest that
invasive human cytotrophoblasts use an unusual repertoire of factors to influence the angiogenic state of maternal blood vessels and that
this cross talk plays an important part in the endovascular component of uterine invasion.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
During development, the human placenta performs a
subset of the functions accomplished after birth by organs of
the body that carry out exchange and transport processes,
e.g., the kidneys, lungs, and digestive system. Like other
organs, the placenta develops its own intrinsic vasculature
that in this case carries blood to and from the fetus. How-
ever, placentation entails a higher order of complexity,
because survival of the conceptus requires this extraembry-
onic structure to form elaborate connections with uterine
vessels, a novel form of vasculogenesis. This process allows
the placenta to tap a supply of maternal blood, a crucial
hurdle for establishing and maintaining pregnancy. To ac-
complish this feat, the placenta’s specialized epithelial cells,
termed cytotrophoblasts, acquire tumor-like properties that
allow them to adhere to the uterus, which they subsequently
invade.
Viewed from a developmental perspective, this unusual
process is the result of cytotrophoblast differentiation along
the invasive pathway. The progenitor population of embry-
onic/fetal cytotrophoblasts, including a stem cell reservoir,
forms a polarized epithelium that is attached to the base-
ment membrane surrounding the stromal cores of chorionic
villi. As differentiation/invasion begins, clusters of cells in
selected regions leave this basement membrane to form
columns of unpolarized cells that attach to and then pene-
trate the uterine wall. The ends of the columns terminate
within the superficial endometrium, where they give rise to
invasive cytotrophoblasts. During interstitial invasion, a
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subset of these cells, either individually or in small clusters,
commingle with resident decidual, myometrial, and immune
cells. During endovascular invasion, masses of cytotropho-
blasts migrate into uterine vessels before the lumina even-
tually recanalize sometime near the end of the first trimester
of pregnancy. Together the two components of cytotropho-
blast invasion anchor the placenta to the uterus and permit
a steady increase in the supply of maternal blood to the
growing fetus.
Work from our group and others suggests that this novel
differentiation program is controlled through the coordi-
nated actions of numerous interrelated factors, such as vas-
cular-endothelial cadherin, several integrins, and Ig super-
family members, that allow the cells to mimic the surface of
vascular cells (Damsky and Fisher, 1998). Matrix metallo-
proteinase-9 also has an important role in invasion (Librach
et al., 1991) and may play novel roles in regulating the
bioavailability of morphogens and growth factors in the
extracellular milieu (Hattori et al., 2002). Upstream regula-
tors include physiological parameters such as oxygen ten-
sion, which triggers either stem cell proliferation in hypoxia
or differentiation/invasion as the cells encounter higher ox-
ygen levels inside the uterine wall (Genbacev et al., 1996,
1997). As in other cells, fate is specified by transcriptional
networks. Those known to play a role in cytotrophoblast
differentiation include factors whose abundance is regulated
by oxygen tension, e.g., the helix–loop–helix factor inhib-
itor of DNA binding protein 2 (Janatpour et al., 2000), and
a mammalian homologue of Drosophila achaete/scute com-
plex genes (Janatpour et al., 1999) that is required for
maintenance of the murine trophoblast stem cell population
(Guillemot et al., 1994). Unexpectedly, a homologue of the
Drosophila neuronal fate gene, glial cells missing-1 (gcm-
1), also plays an important role in the early stages of tro-
phoblast differentiation (Janatpour et al., 1999; Anson-Cart-
wright et al., 2000).
These regulators act in concert with specific growth
factors. Given the unusual vascular phenotype that invasive
cytotrophoblasts adopt and the unique connections they
form with maternal vessels, we have been particularly in-
terested in the cells’ repertoire of substances that influence
vasculogenesis and angiogenesis. We have shown that cy-
totrophoblast differentiation and invasion during the first
and second trimesters of pregnancy are associated with
downregulation of vascular endothelial growth factor
(VEGF) receptor (VEGFR)-2 (Zhou et al., 2002). Invasive
cytotrophoblasts in early gestation expressed VEGF-A,
VEGF-C, placental growth factor (PlGF), VEGFR-1, and
VEGFR-3 and, at term, VEGF-A, PlGF, and VEGFR-1. In
vitro, the cells incorporated VEGF-A into the surrounding
extracellular matrix, whereas PlGF and VEGF-C were se-
creted. We also found that cytotrophoblasts respond to the
VEGF ligands they produce. Blocking ligand binding sig-
nificantly decreased their expression of integrin 1, an ad-
hesion molecule highly expressed by endovascular cytotro-
phoblasts, and increased apoptosis. Our results showed that
VEGF family members regulate cytotrophoblast differenti-
ation, survival, and, consequently, invasion.
The focus of our current studies is the paracrine actions
of angiogenic and vasculogenic factors secreted by cytotro-
phoblasts. We hypothesized that these actions play an im-
portant role in endovascular invasion and in the subsequent
formation of hybrid maternal–fetal vessels within the uter-
ine wall that carry blood to and from the placenta. First, we
investigated cytotrophoblast expression of Ang/Tie family
members that, along with VEGFs, play important roles in
formation of the vasculature (Saaristo et al., 2000; Thurston,
2002; Gale et al., 2002). To assess function, we cultured
isolated endothelial cells in cytotrophoblast-conditioned
medium alone or in medium from which the VEGFs and/or
Ang2 had been removed. We also used the chick cho-
rioallantoic membrane assay to quantify the net angiogenic
effects of early-gestation cytotrophoblast-conditioned me-
dium with or without VEGF-C, PlGF, and/or Ang2.
Materials and methods
Tissue collection
Placentas were obtained immediately after elective ter-
minations of pregnancy (6-22 weeks) or from normal term
deliveries (34–40 weeks), washed thoroughly in phosphate-
buffered saline (PBS) containing antibiotics, and placed on
ice. For in situ hybridization, specimens from the maternal–
fetal interface were immediately fixed in 10% formalin/PBS
at room temperature.
Placental cell isolation and culture
Cytotrophoblasts were isolated either from pools of first-
or second-trimester placentas or from individual third-tri-
mester placentas, as previously described (Kliman et al.,
1986; Librach et al., 1991). Briefly, placentas were sub-
jected to a series of enzymatic digestions that detached
cytotrophoblasts from the underlying stromal cores of the
chorionic villi. Detached cytotrophoblasts were isolated on
a Percoll gradient. The cells were cultured for up to 72 h on
Matrigel-coated substrates (Collaborative Biomedical Prod-
ucts, Bedford, MA) in serum-free Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 4.5 g/liter of glucose
(Sigma Chemical Co., St. Louis, MO), supplemented with
2% Nutridoma (Boehringer Mannheim Biochemicals, Indi-
anapolis, IN), 1% penicillin/streptomycin, 1% sodium pyru-
vate, 1% Hepes, and 1% gentamcin (UCSF Cell Culture
Facility).
Placental fibroblasts were isolated from the denuded
stromal cores of chorionic villi as previously described
(Fisher et al., 1989). The cells were maintained in DMEM
H-21 containing 10% fetal bovine serum, 5% glutamine, 1%
penicillin/streptomycin, and 1% gentamcin. The JAR, JEG,
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and BeWo human choriocarcinoma cell lines were main-
tained as previously described (Fisher et al., 1989).
Northern blot hybridization
Control samples of total RNA extracted from human
heart were purchased from Clontech (Palo Alto, CA). All
other RNA samples were prepared in the laboratory. Some
samples came from specific tissue compartments, such as
cell columns of anchoring villi. Others were from isolated
cells. The latter included purified first-(I), second-(II), and
third-(III)trimester cytotrophoblasts from which total RNA
was obtained either immediately after isolation or after
culture for up to 72 h. Fibroblasts isolated from first-trimes-
ter placentas were used only after the third passage to ensure
the absence of other cell types. RNA was also obtained from
the human choriocarcinoma cell lines JEG, JAR, and BeWo.
Total RNA was isolated according to published methods
(Chomczynski and Sacchi, 1987), and subjected to Northern
blot hybridization as previously described (McMaster et al.,
1995). Before transfer, gels were stained with acridine or-
ange to ensure the integrity of the RNA samples and equal
loading.
Plasmids for Ang1, Ang2, Tie1, and Tie2 were the kind
gift of Regeneron Corporation, Tarrytown, NY. Probe sizes
and sequences were as follows: angiopoietin-1 (570 bp)
including 70 bp of the 5 untranslated region and 500 bp of
the region up to amino acid 166; angiopoietin-2 (640 bp)
including 360 bp of the 5 untranslated region and 280 bp of
the region up to amino acid 99; Tiel (562 bp) including the
ectodomain region (amino acids 162–349); and Tie 2 (508
bp) including the ectodomain region (amino acids 70–239).
The corresponding sense probes were synthesized and used
as controls.
Probes with a specific activity of 2  109 dpm/g were
generated by random priming of the purified fragments
using [32P]dCTP (Amersham Life Sciences-USB, Arlington
Heights, IL) and the Klenow fragment of DNA polymerase
I according to standard methods (Tabor et al., 1993). Hy-
bridization and autoradiography were carried out as previ-
ously described (McMaster et al., 1995).
Immunolocalization
Isolated cytotrophoblasts were processed for double in-
direct immunolocalization by using methods that are stan-
dard in our laboratory (Fisher et al., 1989; Damsky et al.,
1992). Briefly, after 12 h of culture, cells were fixed in cold
acetone for 5 min, then incubated in PBS (4°C) for another
5 min before they were exposed to a mixture of primary
antibodies. The rat anti-human cytokeratin monoclonal an-
tibody 7D3, produced in the Fisher laboratory, was used at
a dilution of 1:50 for immunolocalization. Goat anti-angio-
poietin-2 (R&D Systems, Minneapolis, MN) was used at a
dilution of 1:100. After 1 h, the cells were rinsed in PBS
(4°C) and incubated with the appropriate species-specific
secondary antibodies (Jackson ImmunoResearch Labs, Inc.,
West Grove, PA) conjugated to rhodamine or fluorescein.
Control cells were exposed to only the secondary antibody.
After washing an additional three times in PBS (15 min
total), the coverslips were mounted on slides and examined
with a Zeiss Axiophot epifluorescence microscope (Thorn-
wood, NY). Control cells were incubated in secondary an-
tibody alone.
In situ hybridization
In situ hybridization was carried out by using methods
we previously published (Drake et al., 2001). Labeled
probes were produced from the Ang and Tie plasmids de-
scribed above, and after linearization they were used as
templates for the synthesis of 35S-cRNA probes using T3 or
T7 RNA polymerases.
Ligand depletion of cytotrophoblast-conditioned medium
Conditioned medium was collected from isolated cy-
totrophoblasts after 40 h of culture. The medium was cen-
trifuged before the samples were frozen at 80°C prior to
use. Fusion proteins, consisting of the ligand-binding do-
mains of VEGFR-1, VEGFR-3, or Tie2 fused to the Fc
portion of IgG, and a control CD6-Fc protein were pur-
chased from R&D Systems.
Preliminary experiments were conducted to determine,
by immunoblotting (Zhou et al., 2002), the amount of each
fusion protein that was required to remove the relevant
ligand, and this protein concentration was subsequently
used. Briefly, at the start of each experiment, 1 ml of
conditioned medium was placed in a microfuge tube.
VEGFR-1-Fc (300 ng/ml), VEGFR-3-Fc (4 g/ml), or
Tie2-Fc (5 g/ml) fusion proteins were added separately or
together. The CD6-Fc protein (3 g/ml) was added to the
control samples. Ligand binding was accomplished by in-
cubation, with rotation, for 2 h at 4°C. Afterwards, 100 l
of packed protein A-Sepharose CL-4B beads (Zymed Lab-
oratories, So. San Francisco, CA) was added, and the sam-
ples were incubated/rotated for 2 h at 4°C. Receptor–ligand
complexes were removed by repeated centrifugation. The
supernatants were transferred to new microfuge tubes and
stored at 80°C before use.
To ensure that the medium was depleted of the relevant
ligands, samples containing equal amounts of total protein
were mixed with loading buffer and separated by 15%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
under reducing conditions. After the proteins were trans-
ferred to nitrocellulose, the membranes were incubated with
the following primary goat antibodies diluted 1:1000 in PBS
containing 5% nonfat dried milk and 0.1% Tween 20: anti-
P1GF (Santa Cruz Biotechnology, Santa Cruz, CA); anti-
VEGF-C (R&D Systems); and anti-Ang2 (R&D Systems).
Antibody binding was detected with peroxidase-conjugated
donkey anti-goat IgG (Jackson ImmunoResearch Labs). Im-
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mune complexes were visualized by using an ECL kit and
Hyperfilm (Amersham). Only samples that were 90%
depleted of ligand were used in the in vitro and in vivo
assays.
Uterine microvascular endothelial cell (UtMVEC)
proliferation and apoptosis assays
Human UtMVECs were obtained from BioWhittaker
Inc. (Baltimore, MD). Routinely, the cells were cultured in
EGM-2-MV medium (BioWhittaker Inc.) and used before
the 10th passage. At the start of each experiment, UtMVECs
were resuspended in control or experimental samples of
cytotrophoblast-conditioned medium containing 8% fetal
bovine serum and plated at a density of 4  104/400 l in
8-well chamber slides. After incubation for 12 h, the cells
were quickly washed twice in PBS at room temperature, and
the nuclei were visualized by staining with DAPI (4, 6-
diamidino-2-phenylindole) as previously described (Gen-
bacev et al., 1997). Then, the chambers were removed, and
coverslips were mounted on top of the slides before the total
cell number was counted by using a Zeiss Axiophot epiflu-
orescence microscope. Each condition was tested in tripli-
cate. The entire assay was done four times. Data are ex-
pressed as percentage of controls. The statistical
significance of the results was analyzed by ANOVA.
In preliminary experiments, apoptosis was assessed by
using the terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick-end labeling (TUNEL) method. Briefly,
UtMVECs were cultured for 12 h in experimental or control
samples of conditioned medium as described above. Then,
the cells were fixed in 3% paraformaldehyde for 30 min,
washed twice with PBS, and permeabilized with 0.1% Tri-
ton X-100 in 0.1% sodium citrate for 4 min on ice. Finally,
the UtMVECs were incubated in the TUNEL reaction mix-
ture (Boehringer Mannheim Biochemicals) and DAPI for
1 h at 37°C. The percentage of TUNEL-reactive cells was
determined by using a Zeiss Axiophot epifluorescence mi-
croscope. The results showed TUNEL reactivity and obvi-
ous nuclear fragmentation. Thereafter, apoptosis was scored
by visualizing nuclear morphology after DAPI staining.
Each condition was tested in triplicate. The entire assay was
done three times. The statistical significance of the results
was analyzed by ANOVA.
Chick embryo chorioallantoic membrane (CAM) assay
A modified version of the assay described by Brooks et
al. (1999) was employed. Briefly, fertilized White Leghorn
chicken eggs (California Golden Egg Inc., Petaluma, CA)
were incubated for 10 days at 37°C in 94% humidity to
allow development of embryos with suitable CAMs. A
Fig. 1. Diagram of the histological organization of the human maternal–fetal interface at midgestation. Cytotrophoblasts, which are specialized (fetal)
epithelial cells of the placenta, differentiate and invade the uterine wall (interstitial invasion), where they also breach maternal blood vessels (endovascular
invasion). The basic structural unit of the placenta is the chorionic villus, composed of a stromal core with blood vessels, surrounded by a basement membrane
and overlain by cytotrophoblasts. As part of their differentiation program, these cells detach from the basement membrane and adopt one of two lineage fates.
They either fuse to form the multinuclear syncytiotrophoblasts that cover floating villi (FV) or join a column of mononuclear extravillous cytotrophoblasts
at the tips of anchoring villi (AV). The syncytial covering of floating villi mediates the nutrient, gas and waste exchange between fetal and maternal blood.
The anchoring villi, through the attachment of cytotrophoblast columns, establish physical connections between the fetus and the mother. Invasive
cytotrophoblasts penetrate the uterine wall up to the first third of the myometrium. A portion of the extravillous cytotrophoblasts home to uterine spiral
arterioles and remodel these vessels by replacing the endothelial lining and intercalating within the muscular walls. To a lesser extent, they also remodel
uterine veins. Diagram modified from Hoang et al. (2001).
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small hole was made with a drill (Dremel-Emerson Electric,
Racine, WI) directly over the air sac at the broad end of the
egg, which was candled to determine the drilling site of a
second hole directly over the CAM. Gentle pressure was
applied with forceps through the second hole to drop the
CAM. Then, a grinding wheel (Dremel-Emerson Electric)
was used to cut a 1  1-cm2 window in the eggshell over
the dropped CAM. Ten microliters of a 3-mg/ml solution of
cortisone acetate was applied to a sterilized disk of What-
man type I filter paper, 6 mm in diameter, which was
allowed to air dry in a tissue culture hood before it was
placed through the eggshell window onto the center of the
CAM. Then, 80 l of control or experimental medium, the
maximum absorbable volume, was loaded onto each disk.
The window was sealed with sterile transparent tape, and
the eggs were incubated at 37°C. After 48 h, the CAM was
dissected from the disk. The entire area that was directly
exposed to the disk was imaged by using a Zeiss M2 Mat
dissection microscope and photographed with a SPOT dig-
ital camera (Stemi 2000C; Diagnostic Instruments, Inc.,
Sterling Heights, MI). In each experiment, the angiogenic
response induced by samples of control and experimental
conditioned medium was evaluated by using six to eight
eggs. The entire assay was conducted seven times. The
angiogenic response was quantified by counting the total
number of capillaries that formed beneath the disk. The
mean capillary density was calculated for each sample and
expressed as a percentage of the control. VEGF-A (R&D
Fig. 2. In vitro, human placental cytotrophoblasts primarily express Ang2 at the mRNA and protein levels. Cytotrophoblasts were isolated from first- (I),
second-(II), and third-(III) trimester human placentas. mRNA was prepared from cells immediately after they were isolated (0 h) or after they were plated
on Matrigel for up to 72 h, during which time they fully differentiated and assumed the phenotype of cytotrophoblasts that invade the uterus in vivo. (A)
Neither cultured cytotrophoblasts nor the JAR choriocarcinoma cell line expressed Ang1 mRNA. In contrast, an mRNA sample from a fibroblast line
established from first-trimester human placentas contained a band corresponding to an Ang1 mRNA of the expected size. (B) Cultured cytotrophoblasts
expressed Ang2 mRNA during all stages of differentiation; 2.1- and 3-kb mRNAs that encode the same protein were detected. The same two transcripts
were detected in samples isolated from nascent cell columns that were dissected from anchoring villi. Choriocarcinoma cells (JEG, JAR, and BeWo), placental
fibroblasts, and heart samples contained the 2.1-kb mRNA. (C) Cytotrophoblasts that were cultured overnight were analyzed by double indirect immuno-
localization. (a) The cells stained for cytokeratin (CK), a unique feature that distinguishes them from other types of placental cells, including fibroblasts and
endothelia. (b) The cells also stained with an antibody that specifically reacts with Ang2.
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Systems) dissolved in serum-free medium at a concentration
of 5 ng/ml was used as a positive control. The statistical
significance of the data was analyzed by ANOVA.
Results
First, we investigated cytotrophoblast expression of Tie
receptors and their angiopoietin ligands during human cy-
totrophoblast differentiation/invasion in vitro and in situ.
Northern blot hybridization failed to detect expression of
either the Tie1 or the Tie2 receptor (data not shown). In
contrast, control human microvascular endothelial cells ex-
pressed mRNA encoding both receptors. With regard to
ligands, Ang1 mRNA expression was detected in human
first-trimester placental fibroblasts, most likely a reflection
of the angiogenic environment of the stromal cores of cho-
Fig. 3. In situ hybridization shows that syncytiotrophoblasts and cytotrophoblasts express Ang2 mRNA in vivo. Sections of anchoring villi and the portion
of the uterine wall to which they attached were hybridized to anti-sense probes to detect Ang1 and Ang2 mRNA expression. No specific Ang1 signals were
observed in association with any of the trophoblast populations (data not shown). In contrast, the hybridization pattern of the Ang2 anti-sense probe suggested
that the corresponding mRNA was strongly expressed in both the syncytiotrophoblast (STB) and cytotrophoblast (CTB) populations of floating villi (data
not shown) and anchoring villi (A and B). In contrast, cells in the cytotrophoblast cell column (CC) gave no signal. (C) The control Ang2 sense probe did
not give specific hybridization signals. (D and E) As cytotrophoblasts left the columns and invaded beyond the surface of the uterine wall, the cells
upregulated Ang2 mRNA expression. (F and G) Cytotrophoblasts anchored to the walls of maternal blood vessels also showed strong hybridization to the
anti-sense Ang2 probe, while cytotrophoblasts in the lumina of these vessels did not.
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rionic villi, where the intrinsic vasculature of the placenta
develops (Fig. 1). No hybridization signal was detected in
first-trimester, second-trimester, or term cytotrophoblasts
(Fig. 2A), either immediately after their isolation (0 h) or
after they had differentiated in vitro for 36 h, during which
time they assume a vascular phenotype. Likewise, we failed
to detect Ang1 expression by the JAR choriocarcinoma
(human malignant trophoblast) cell line (Fig. 2A).
In contrast, cytotrophoblast expression of Ang2 mRNA
was detected during all three gestational periods studied and
at all stages of differentiation in vitro (0–36 or 0–72 h of
culture). The cDNA probe hybridized to a band of 2.1 kb,
the only mRNA found in samples isolated from placental
fibroblasts, the choriocarcinoma cell lines (JEG, JAR, and
Be Wo), and heart (Fig. 2B). The same probe hybridized to
bands of 2.1 and 3 kb in nearly all the RNA samples
isolated from cell columns dissected from placental villi
(see Fig. 1) and in cytotrophoblasts cultured for up to 72 h.
Fig. 4. PlGF, VEGF-C, and Ang2 in cytotrophoblast-conditioned medium support the growth of UtMVECs in vitro. Cells cultured in cytotrophoblast-
conditioned medium (CTB CM) grew at the same rate as when the cells were cultured in medium specially formulated to support their propagation
(EGM-2-MV; data not shown). (A) Treatment of the medium with an irrelevant fusion protein, CD6-Fc, did not change growth rate. In contrast, treatment
of the medium with VEGFR-1 (VR1-Fc), which removes PlGF, resulted in an60% decrease in the number of endothelial cells, as did treatment with fusion
proteins that removed VEGF-C (VR3-Fc) or Ang2 (Tie2-Fc). Removal of Ang2, VEGF-C, and PlGF resulted in a 95% reduction in attached endothelial cells
as compared with the control wells. (B) The reduction in the number of endothelial cells in cultures grown in cytotrophoblast-conditioned medium that was
depleted of angiogenic factors was directly attributable to apoptosis. Bars show the standard deviation of the mean values. The significance of the data from
four separate experiments was determined by ANOVA.
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Both mRNAs encode the same Ang2 protein (Dr. Hao
Zhou, Regeneron Corp.; personal communication). In gen-
eral, no obvious pattern of Ang2 regulation was observed
during differentiation of cells isolated from first-trimester or
term placentas. In contrast, cytotrophoblasts isolated from
second-trimester placentas consistently exhibited an up-
regulation of Ang2 mRNA expression during the early
stages of differentiation in vitro. This observation is in
accord with our published data showing that cytotrophoblast
pseudovasculogenesis peaks during this period (Fig. 2B)
(Zhou et al., 1997a). Finally, we assayed the cells’ expres-
sion of Ang2 at the protein level (Fig. 2C). Isolated cytotro-
phoblasts that were cultured for 12 h stained brightly with
an antibody that specifically reacts with this ligand, showing
that the cells translated the Ang2 mRNA we detected into
protein.
To determine whether the expression patterns of Tie
receptors and their Ang ligands were the same in vitro and
in vivo, we performed in situ hybridization on tissue sec-
tions from the maternal–fetal interface that contain cytotro-
phoblasts in all stages of differentiation (Fig. 1). Consistent
with the Northern blot hybridization experiments, we failed
to detect Tie1, Tie2, or Ang1 mRNA expression among any
of the trophoblast populations (data not shown). In contrast,
these cells expressed Ang2 mRNA (Fig. 3). Syncytiotro-
phoblasts, which cover the surfaces of chorionic villi and
are in direct contact with maternal blood, gave a strong
signal, as did the underlying layer of progenitor cytotropho-
blasts (Fig. 3A and B). No signal was detected when an
Ang2 sense probe was hybridized to an adjacent tissue
section (Fig. 3C). We failed to detect Ang2 mRNA expres-
sion in the proximal regions of cytotrophoblast columns that
attach the placenta to the uterus (Fig. 3B and E). However,
strong Ang2 signals were once again observed in associa-
tion with cytotrophoblasts that invaded beyond the surface
of the uterine wall (Fig. 3E). Likewise, cytotrophoblasts that
lined maternal vessels expressed Ang2 mRNA, while those
that occupied the lumina did not (Fig. 3G).
Next, we assessed in vitro and in vivo the paracrine
actions of the vasculogenic/angiogenic substances that cy-
totrophoblasts secrete, principally Ang2, PlGF and
VEGF-C. First, we examined the effects of these factors,
both individually and in combination, on UtMVECs in vitro
(Fig. 4A). Cytotrophoblast-conditioned medium promoted
the growth of these cells at a rate that was comparable to
their growth rate in their usual medium. Treating the me-
dium with an irrelevant fusion protein (CD6-Fc) did not
change the rate of endothelial cell mitosis or the appearance
of the cells. However, treatment of the medium with
VEGFR-1 [1–3]-Fc, which removes PlGF, resulted in an
60% decrease in the number of endothelial cells, as did
treatment with fusion proteins that removed VEGF-C
(VEGFR-3 [1–3]-Fc) or Ang2 (Tie2-Fc). Many of the re-
maining cells had pyknotic nuclei and a shriveled appear-
ance. Removal of Ang2, VEGF-C, and PlGF resulted in a
95% reduction in attached endothelial cells as compared
with the control. Morphological changes in the remaining
cells were exacerbated.
The morphology of the endothelial cells suggested that
apoptosis was playing a large role in reducing the number of
endothelial cells in cultures that were maintained in cytotro-
phoblast-conditioned medium depleted of angiogenic fac-
tors. As shown in Fig. 4B, no apoptosis was observed when
the cells were cultured in conditioned medium treated with
a control fusion protein (CD6-Fc). In contrast, many cells
exhibited TUNEL reactivity and nuclear fragmentation, in-
dicative of apoptosis, when PlGF, VEGF-C, or Ang2 was
removed. This effect was exacerbated when cytotropho-
blast-conditioned medium was depleted of all three factors.
Finally, we assessed the angiogenic effects of factors in
cytotrophoblast-conditioned medium in the chick cho-
rioallantoic membrane assay. The membranes were photo-
graphed after application of the various conditioned me-
dium samples (Fig. 5A), and the number of new capillary
sprouts was counted (Fig. 5B). The medium was assayed
without treatment (Fig. 5A[a]) or after treatment with a
control CD6-Fc protein (Fig. 5A[b]). In both cases, a robust
angiogenic response was detected that was comparable to
the response induced by adding either basic FGF (data not
shown) or recombinant VEGF to the medium (Fig. 5A[c]).
Removal of PlGF (Fig. 5A[d]), VEGF-C (Fig. 5A[e]), or
Ang2 (Fig. 5A[f]) diminished this effect by approximately
70–80%. However, depletion of all three factors produced
no further decrease in the angiogenic capacity of cytotro-
phoblast-conditioned medium (Fig. 5A[g]), suggesting that
compensatory factors have partial effects in this in vivo
model.
Discussion
The results of these experiments support the important
concept that, during early human pregnancy, cytotropho-
blasts produce factors that act in a paracrine manner to
influence the angiogenic state of uterine vessels. We previ-
ously studied the autocrine actions of VEGF family ligands
(Zhou et al., 2002), including the promotion of cytotropho-
blast differentiation/invasion and survival. Here, we show
that cytotrophoblasts and syncytiotrophoblasts in floating
villi and cytotrophoblasts that invade beyond the uterine
surface, where they occupy maternal vessels, synthesize
Ang2 but not Ang1, Tie1, or Tie2. The cells’ lack of recep-
tor expression suggests that Ang2 has paracrine rather than
autocrine actions.
These findings are in general agreement with the results
of some investigators (Goldman-Wohl et al., 2000) but
differ from the reports of those who also detected tropho-
blast Ang1 expression (Dunk et al., 2000; Zhang et al.,
2001). Our results were bolstered by additional data show-
ing that purified cytotrophoblasts express only Ang2 mRNA
in vitro. Knowing the identity of the major vasculogenic
substances secreted by cytotrophoblasts allowed us to assess
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their functions. All three ligands contributed to the survival
of purified UtMVECs in culture, an effect that was additive.
Likewise, all three factors promoted a strong angiogenic
response in the chick chorioallantoic membrane assay, al-
though the effects were not additive, suggesting functional
redundancy. Together, these findings give additional mech-
anistic insights into the highly unusual process that enables
trophoblasts to invade and occupy maternal blood vessels,
an essential feature of hemochorial placentation. Our find-
ings also suggest that, in humans, PlGF, VEGF-C, and
Ang2 are essential to this process.
The actions of Ang2 are complex (Veikkola and Alitalo,
2002). For example, Ang2 expression is characteristic of
neovascular endothelium (Holash et al., 1999), but high
Ang2 expression is also observed during regression of the
corpus luteum (Maisonpierre et al., 1997). These apparently
contradictory findings can be explained by considering
Ang2 actions in the context of VEGF levels. When levels of
both ligands are high, Ang2 promotes vessel destabilization,
favoring angiogenesis. In the absence of VEGF, Ang2 pro-
motes endothelial apoptosis (Holash et al., 1999). When we
assessed the effects on isolated endothelial cells of tropho-
blast-derived PlGF, VEGF-C, and Ang2, alone and in com-
bination, our results were consistent with this interpretation.
Fig. 5. PlGF, VEGF-C, and Ang2 in cytotrophoblast-conditioned medium stimulate angiogenesis in vivo. The angiogenic effects of factors in cytotrophoblast-
conditioned medium were assessed by using the chick chorioallantoic membrane assay as described in Materials and methods. (A) The membranes were
photographed after exposure to the samples for 48 h. Cytotrophoblast-conditioned medium (a) and medium treated with a control CD6-Fc protein (b) induced
a robust angiogenic response that was comparable to the response induced by addition of 5 ng/ml recombinant VEGF-A (c). Removal of PlGF (d), VEGF-C
(e), or Ang2 (f) diminished this effect by 70–80%. (g) Depletion of all three factors produced no further decrease in the angiogenic capacity of
cytotrophoblast-conditioned medium. (B) The data were quantified by counting the number of new capillary sprouts. Data are expressed as means and
standard deviations of seven experiments. The significance of the data from four separate experiments was determined by ANOVA. CM, conditioned medium;
SFM, serum-free medium.
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Recent gene knockout experiments in mice provide further
insights into the unusual nature of Ang2 actions (Gale et al.,
2002). The homozygous null animals (Ang2/) do not
display defects in angiogenesis before birth, but postnatal
angiogenesis is disrupted. For example, Ang2 knockout
mice show impaired retinal blood vessel development be-
cause they are unable to initiate sprouting of the central
retinal artery, which normally occurs in a VEGF-rich envi-
ronment. This defect was not rescued by Ang1, suggesting
that postnatal angiogenesis is a unique function of Ang2.
Another surprising result of the gene knockout experi-
ments was the observation that Ang2/ animals also show
a defect in patterning of the dermal and intestinal lymphatic
capillaries (Gale et al., 2002). Specifically, the smooth mus-
cle portions of the vessel walls fail to assemble properly.
The phenotype of these animals resembles the consequences
of heterozygous missense mutations that inactivate the
VEGFR-3 tyrosine kinase (Karkkainen et al., 2000). In
keeping with these findings, the receptor’s ligand, VEGF-C,
also plays a major role in lymphatic development (Jeltsch et
al., 1997). During trophoblast invasion of the uterine wall
and associated vessels, the cells express many of the same
molecules that regulate lymphatic development: VEGF-C,
VEGFR-3 (Zhou et al., 2002), and Ang2 (this report). These
observations suggest that the highly specialized, cytotro-
phoblast-lined uterine vessels that carry blood to the pla-
centa may in some ways resemble the lymphatic vascula-
ture. This hypothesis could help explain the vessels’
unusually dynamic behavior that allows for enormous ex-
pansion in size without the loss of compliance.
Maternal vessels are also exposed to cytotrophoblast-
derived PlGF, which can displace VEGF-A, bind to
VEGFR-2, and initiate angiogenic signals (Park et al.,
1994). PlGF actions appear to be especially important in the
pathological growth of blood vessels. In the absence of this
ligand, ischemia- and tumor-induced angiogenesis are
downregulated without untoward effects on the normal
physiological counterparts of these processes (Carmeliet et
al., 2001). Recently, investigators exploited the molecule’s
relatively limited spectrum of actions to show that PlGF
induces, with efficiency comparable to that of VEGF, re-
vascularization of ischemic myocardium and limbs without
affecting healthy tissues (Luttun et al., 2002). Of particular
relevance to our studies is the fact that this ligand stimulated
“arteriogenesis”—the formation of mature, durable, and
functional arteries that did not regress once the angiogenic
stimulus was removed. PlGF’s actions on multiple targets,
including endothelial and smooth muscle cells, as well as
the recruitment of inflammatory cells, likely explain this
effect. The same properties that make PlGF an interesting
candidate for therapeutic angiogenesis also make this ligand
an ideal component of the unusual strategy that cytotropho-
blasts use to remodel maternal vessels, particularly arteries.
In this regard, it is evident that the cells largely avoid
secretion of ligands that play an important role in conven-
tional angiogenic processes.
It is tempting to speculate that pregnancy conditions that
are associated with faulty endovascular invasion could be
the downstream consequences of cytotrophoblast misex-
pression of PlGF, VEGF-C, and/or Ang2. Preeclampsia, one
of the leading causes of maternal mortality in the Western
world, also increases perinatal mortality fivefold (Walker,
2000). The clinical diagnostic criteria for this syndrome
include the new onset of hypertension and the appearance of
proteinuria and edema during pregnancy (Roberts et al.,
1989). Preeclampsia and about half the cases of intrauterine
growth restriction are associated with particular placental
pathologies. The extent of interstitial invasion by cytotro-
phoblasts is variable but frequently shallow, and endovas-
cular invasion is consistently rudimentary (Brosens et al.,
1972; Zhou et al., 1997b). These anatomical defects sug-
gested to us that, in preeclampsia, cytotrophoblast differen-
tiation along the invasive pathway is abnormal. Biopsy
specimens from the uterine wall of women with this syn-
drome showed that invasive cytotrophoblasts retain expres-
sion of adhesion receptors characteristic of the precursor
pool of cytotrophoblasts and fail to turn on receptors that
promote invasion and/or assumption of an endothelial phe-
notype (Zhou et al., 1997a). The chain of events that initiate
faulty cytotrophoblast differentiation is not known, but an
imbalance in the factors that coordinate cytotrophoblast
differentiation/invasion with remodeling of the uterine ar-
teries, including PlGF, VEGF-C, and Ang2, could be in-
volved. For example, in preeclampsia, cytotrophoblasts
within the uterine wall undergo massive apoptosis (pro-
grammed cell death); this could be related to the actions of
Ang2 in the absence of VEGF-A, a scenario that leads to
programmed cell death (Holash et al., 1999). In support of
this theory, we recently reported that cytotrophoblast ex-
pression of VEGF-A is downregulated in severe preeclamp-
sia as compared with uncomplicated pregnancies (Zhou et
al., 2002). Experiments to determine whether Ang2 contin-
ues to be expressed in preeclampsia are in progress. Given
that overexpression of PlGF and VEGF-C causes increased
vessel permeability (Odorisio et al., 2002; Saaristo et al.,
2002), and an excess of Ang2 leads to blood vessel disrup-
tion (Maisonpierre et al., 1997), it is possible that an over-
abundance of these factors could also be detrimental.
Finally, work from our laboratory and from other inves-
tigators (e.g., Charnock-Jones, 2002; Matsumoto et al.,
2002) allows us to suggest a model that integrates what we
have learned thus far about the molecular basis of cytotro-
phoblast invasion of the uterus eventually leading to occu-
pation of the uterine vessels. We know that oxygen tension,
hypoxia in particular, is a critical factor in stimulating cy-
totrophoblast proliferation and self-renewal. The von Hip-
pel-Lindau tumor suppressor protein (pVHL), which cy-
totrophoblasts upregulate under conditions of low oxygen
tension (Genbacev et al., 2001), protects them from the
normal spectrum of hypoxia-induced responses, including
cell cycle exit. As the cells migrate into the uterus, they
encounter a positive oxygen tension gradient that triggers
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pVHL degradation and the stabilization of hypoxia-induc-
ible factor 2 alpha. This transcription factor positively reg-
ulates the production of vasculogenic/angiogenic factors
that, in other cells, include VEGF-A (Enholm et al., 1997),
PlGF (Green et al., 2001), and Ang2 (Mandriota and Pep-
per, 1998). These data suggest that a similar effect may
occur in cytotrophoblasts. In contrast, VEGF-C expression
appears to be stimulated by growth factors and cytokines
(Ristimaki et al., 1998). The actions of soluble factors are
consistent with evidence suggesting that maternal arterioles
undergo structural changes before directly interacting with
cytotrophoblasts (Craven et al., 1998). We suspect that these
factors directly or indirectly affect the expression of the
downstream regulators, including adhesion molecules
(Damsky and Fisher, 1998) and MMP-9 (Librach et al.,
1991), that carry out uterine invasion and vascular remod-
eling. Whether or not elements of this strategy could be
exploited for therapeutic angiogenesis of ischemic condi-
tions is an interesting question that has yet to be addressed.
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